Riskpilot← Back to searchSign inGet full accessNjord Medical AB
ABActiveOrg 5591741821Fiskbodavägen 25General medical practice activities · NACE 8621Est. 20181 employees
Revenue 2025
SEK 1,3M
+1% vs 2024
EBITDA margin
19.2%
+89% vs 2024
Equity ratio
42.8%
Financial strength
Net profit 2025
SEK 198K
+93% vs 2024
| Revenue | SEK 1,3M | +1% |
| EBITDA | SEK 254K | +89% |
| Net profit | SEK 198K | +93% |
| Total assets | SEK 676K | +3% |
| Equity | SEK 290K | +7% |
| Employees | 1 | — |
Legal name
Njord Medical AB
Org number
5591741821
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
5 oktober 2018
Share capital
SEK 50 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Aktiebolaget ska bedriva medicinsk konsultverksamhet inom men ej begränsad till sjukvård inrikes och utrikes, verksamhet som omfattar dykutbildning, dykguidning och dykmedicin samt bedriva därmed förenlig verksamhet.
Address
Fiskbodavägen 25
Email
sarah_jarnald@yahoo.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 459 | 387 | 1 091 | 1 314 | 1 326 |
| Staff expenses | — | — | −505 | −983 | −887 |
| EBITDA | 313 | 201 | 460 | 134 | 254 |
| Depreciation & amort. | −0 | −0 | — | — | — |
| EBIT | 313 | 201 | 460 | 134 | 254 |
| Net financials | — | — | 0 | 3 | 2 |
| Profit before tax | 312 | 201 | 461 | 137 | 256 |
| Tax | −73 | −52 | −104 | −34 | −58 |
| Net profit | 239 | 149 | 357 | 102 | 198 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 488 | 392 | 714 | 654 | 676 |
| Equity | 303 | 232 | 424 | 271 | 290 |
| Long-term debt | 0 | 0 | −55 | 0 | — |
| Short-term debt | 185 | 160 | 345 | 382 | 386 |
| Total debt | 185 | 160 | 290 | 382 | 386 |
EBITDA margin
19.2%
This company
15.8%
Market median
+22% vs market
20212025
Equity ratio
42.8%
This company
38.2%
Market median
+12% vs market
20212025
Return on equity
68.4%
This company
18.4%
Market median
+272% vs market
20212025
Net profit margin
14.9%
This company
8.1%
Market median
+84% vs market
20212025
Asset turnover
1.96×
This company
1.12×
Market median
+75% vs market
20212025
Debt / equity
1.33×
This company
0.62×
Market median
-115% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Njord Medical AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Sarah Carolina Jarnald | Board of Directors | 0 companies |
| Per Nils Johan Viklund | Deputy Board Member | 0 companies |